Introduction {#S001}
============

Alzheimer's disease (AD) is the most common neurodegenerative disorder and is characterized by amyloid plaques, neurofibrillary tangles, and loss of neurons (Mattson [@CIT0042]). There are several hypotheses to explain the cause of AD (Hardy & Higgins [@CIT0018]; Markesbery [@CIT0041]; Francis et al. [@CIT0015]; Hardy & Selkoe [@CIT0017]; Berridge [@CIT0004]; Maccioni et al. [@CIT0040]). Among them, the amyloid hypothesis states that most of AD pathologies are caused by deposition of amyloid-β42 (Aβ42) peptide, which is generated by proteolytic processing of the amyloid precursor protein (Hardy & Higgins [@CIT0018]).

Based on well-developed genetic tools, such as the upstream activation sequence (*UAS*)*-GAL4* system, by which the expression of desired genes can be regulated, *Drosophila* has been used as an animal model to study AD (Lee et al. [@CIT0031], [@CIT0030]; Bang et al. [@CIT0003]). To date, different groups have generated several different transgenic lines that can be used for the ectopic expression of human *Aβ42*. In the present study, we selected four lines to investigate the relationship between transgene structure and their functions ([Table 1](#T0001){ref-type="table"} and [Figure 1](#F0001){ref-type="fig"}). *UAS-Aβ42^2X^* (Casas-Tinto et al. [@CIT0007]) contains two serially concatenated copies of the transgene with an argos signal peptide and SV40 poly A tail ([Figure 1](#F0001){ref-type="fig"}). *UAS-Aβ42^BL33770^* (Singh & Mahoney [@CIT0046]) contains one copy of the transgene with the argos signal peptide and the *Drosophila α-tubulin* 3′ untranslated region (UTR) ([Figure 1](#F0001){ref-type="fig"}). The *α-tubulin* 3′ UTR is thought to provide stability to transgenes linked with it (Ollmann et al. [@CIT0043]; Liu et al. [@CIT0037]); it is supposed to increase Aβ42 protein levels by prolonging the RNA half-life. *UAS-Aβ42^11C39^* (Iijima et al. [@CIT0022]) and *UAS-Aβ42^H29.3^* (Finelli et al. [@CIT0014]) both contain a copy of same transgene with a pre-proenkephalin signal peptide and an SV40 poly A tail ([Figure 1](#F0001){ref-type="fig"}). Figure 1.Constructs in four different *UAS-Aβ42* lines. The schematic figures show the constructs in the four *UAS-Aβ42* lines, *UAS-Aβ42^2X^*, *UAS-Aβ42^BL33770^*, *UAS-Aβ42^11C39^*, and *UAS-Aβ42^H29.3^*, which have differences in the number of copies, signal peptides, and poly A tails. *UAS-Aβ42^2X^* has two copies of the *UAS-Aβ42* sequence, while the others have one copy. *UAS-Aβ42^2X^* and *UAS-Aβ42^BL33770^* have the signal peptide-encoding region of the fly *argos* gene, whereas *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^* have that of the rat *pre-proenkephalin* gene. *UAS-Aβ42^BL33770^* carries the poly A tail of *α-tubulin*, and the others contain that of *SV40*.Table 1.The list of studies in that used the *UAS-Aβ42* transgenic lines.LinePublication2X**Casas-Tinto et al. 2011. *Hum Mol Genet* 20(11):2144--2160**Ambegaokar & Jackson 2011. *Hum Mol Genet* 20(24):4947--4977Fernandez-Funez et al. 2015. *Hum Mol Genet* 24(21):6093--6105BL33770Liu et al. 2015. *Biol Pharm Bull* 38(12):1891--1901Lee et al. 2016. *Dis Model Mech* 9(3):295--306Chouhan et al. 2016. *Acta Neuropathol Commun* 4(1):62Liu et al. 2016. *Am J Chin Med* 44(7):1325--134711C39**Iijima et al. 2008. *PLoS One* 3(2):e1703**Iijima-Ando et al. 2008. *J Biol Chem* 283(27):19066--19076Chiang et al. 2009. *FASEB J* 23(6):1969--1977Chiang et al. 2010. *Proc Natl Acad Sci USA* 107(15):7060--7065Iijima et al. 2010. *Hum Mol Genet* 19(15):2947--2957Lee et al. 2012. *Nat Commun* 3:1312Wang et al. 2012. *Proc Natl Acad Sci USA* 109(41):16743--16748Lang et al. 2012. *PLoS Genet* 8(4):e1002683Lang et al. 2013. *Neurobiol Aging* 34(11):2604--2612Lin et al. 2014. *Aging Cell* 13(3):507--518Ando et al. 2016. *PLoS Genet* 12(3):e1005917H29.3**Finelli et al. 2004. *Mol Cell Neurosci* 26(3):365--375**Cao et al. 2008. *Genetics* 178(3):1457--1471Ling et al. 2009. *PLoS One* 4(1):e4201Sanokawa-Akakura et al. 2010. *PLoS One* 5(1):e8626Ling & Salvaterra 2011. *Acta Neuropathol* 121(2):183--191Lee et al. 2011. *Mol Cells* 31(4):337--342Hong et al. 2012. *Biochem Biophys Res Commun* 419(1):49--53Lüchtenborg & Katanaev 2014. *Mol Brain* 7:81Liu et al. 2015. *Biol Pharm Bull* 38(12):1891--1901Lee et al. 2016. *Dis Model Mech* 9(3):295--306Gerstner et al. 2016. *J Neurosci Res* DOI:[10.1002/jnr.23778](https://doi.org/10.1002/jnr.23778)Liu et al. 2016. *Am J Chin Med* 44(7):1325--1347

Although several *Drosophila Aβ42* transgenic lines were developed and used in a variety of studies, their phenotypic differences have not been studied in detail. Therefore, we compared the phenotypes of the four representative *UAS-Aβ42* lines under the same experimental conditions. They showed different *Aβ42* expression levels and phenotypic severity in eyes and neurons. Interestingly, the level of reactive oxygen species (ROS) generation did not correlate with survival rate in this comparative study.

Materials and methods {#S002}
=====================

*Drosophila* strains {#S002-S2001}
--------------------

Glass multimer reporter (*GMR*)-*GAL4* (BL9146), embryonic lethal abnormal vision (*elav*)-*GAL4* (BL458), and *UAS-Aβ42^BL33770^* (BL33770) were acquired from the Bloomington *Drosophila* Stock Center. *UAS-Aβ42^2X^*, *UAS-Aβ42^H29.3^*, and *UAS-Aβ42^11C39^* were provided by Dr Pedro Fernandez-Funez (University of Florida, USA), Dr Mary Konsolaki (University of Rutgers, USA), and Dr Koichi M. Iijima (University of Thomas Jefferson, USA), respectively.

Thioflavin S staining {#S002-S2002}
---------------------

Thioflavin S staining was performed as described previously by Iijima et al. ([@CIT0024]). Whole brains were dissected, permeabilized, and incubated overnight at 4°C in 50% ethanol containing 0.125% thioflavin S (Sigma-Aldrich). The samples were rinsed with 50% ethanol and phosphate buffered saline (PBS) containing 0.5% Triton X-100, and examined using confocal microscopy.

Immunohistochemistry {#S002-S2003}
--------------------

Immunohistochemistry was performed as described previously by Jeong et al. ([@CIT0025]). Whole brains were dissected and blocked with 5% normal goat serum and 2% bovine serum albumin in PBS containing 0.5% Triton X-100. They were incubated for 48 h with anti-Aβ42 antibodies (1:200; Santa Cruz Biotechnology) at 4°C and washed four times with PBS containing 0.5% Triton X-100. Samples were then incubated overnight with Alexa-Fluor-488-labeled anti-mouse antibody (1:200; Invitrogen) at 4°C and washed four times with PBS containing 0.5% Triton X-100.

Acridine Orange staining {#S002-S2004}
------------------------

Acridine orange (AO) staining was performed as described previously by Hong et al. ([@CIT0019]) and Park et al. ([@CIT0044]). The eye discs of stage L3 larvae were dissected rapidly in PBS and incubated for 5 min with 1.6 × 10^−6^ M AO (Sigma-Aldrich). After rinsing twice for 5 min in PBS, the samples were analyzed using a fluorescence microscope (Carl Zeiss).

Dihydroethidium staining {#S002-S2005}
------------------------

For dihydroethidium (DHE) staining, the eye discs of stage L3 larvae were dissected in Schneider's medium at room temperature, and incubated with Schneider's medium containing the 3.0 × 10^−6^ M DHE dye (Invitrogen Molecular Probes) for 5 min in the dark. They were then washed with Schneider's medium, and observed under a fluorescence microscope (Carl Zeiss).

Analysis of *Drosophila* development {#S002-S2006}
------------------------------------

Fifty embryos of each genotype were collected in vials that contained standard cornmeal media and incubated at 25°C. Survival scores (the ratio of the number of adult male flies raised from collected embryos against half the total number of collected embryos) were obtained for each group. The experiment was repeated six times.

Climbing assay {#S002-S2007}
--------------

The climbing assay was performed as previously reported by Hwang et al. ([@CIT0020]) with some modifications. The experiment was conducted with 80 male flies. Ten male flies were collected in each climbing assay vial, and the flies were tapped down to the bottom of the vial. Then, the number of flies that climbed to the top of the vial within 15 s was counted. Ten trials were performed for each group. Climbing scores (the ratio of the number of flies that reached the top against the total number of flies) were obtained for each group, and the mean climbing scores for the 10 repeated tests were compared.

Statistics {#S002-S2008}
----------

In all experiments, data were analyzed using one-way ANOVA followed by a Tukey--Kramer multiple comparison test. Statistical results were exhibited as means ± SEM. Decisive values were expressed by asterisks (\**p* \< .05, \*\**p* \< .01, and \*\*\**p* \< .001). Eye size was gauged using ImageJ software (National Institutes of Health).

Results {#S003}
=======

The levels of Aβ42 protein and its aggregates in the developing eyes and brains of *Drosophila* AD models {#S003-S2001}
---------------------------------------------------------------------------------------------------------

To characterize the four different *Aβ42* transgenic lines, we measured the levels of Aβ42 aggregates and its protein abundance. As expected, the Aβ42 protein and its aggregation level in both the developing eyes and brain were the highest in the *UAS-Aβ42^2X^* line ([Figure 2](#F0002){ref-type="fig"}), which contains two copies of the *Aβ42* transgene ([Figure 1](#F0001){ref-type="fig"}). The second highest was the *UAS-Aβ42^BL33770^* line ([Figure 2](#F0002){ref-type="fig"}), which has an argos signal peptide and poly A tail of fly *α-tubulin* ([Figure 1](#F0001){ref-type="fig"}). The expression level of Aβ42 protein by the *UAS-Aβ42^11C39^* line was higher than that of *UAS-Aβ42^H29.3^* ([Figure 2](#F0002){ref-type="fig"}), despite having *Aβ42* transgenes with the same structure ([Figure 1](#F0001){ref-type="fig"}), which suggested that their difference might be caused by a position effect. Figure 2.The Aβ42 levels and extent of aggregation in the eye imaginal discs (a--c) and the adult brains (d--f) of the flies expressing different *Aβ42* transgenes. Representative images of thioflavin S staining (a, b, d, e) and Aβ42-immunostaining (c, f) in eye imaginal discs and adult brains. (b) and (c) correspond to the dotted area in (a), while (e) and (f) correspond to the dotted area in (d). The human *Aβ42* transgenes were expressed in *Drosophila* eye imaginal discs at 29°C and neurons at 25°C, respectively. Magnification of the pictures: (a) ×200, (b, c, e, f) ×400, and (d) ×100.

We also measured Aβ42 aggregate levels by thioflavin S staining, which is a commonly used method to detect amyloid fibrils, but not monomers (Yamamoto & Hirano [@CIT0048]). The levels of Aβ42 aggregates were proportional to the protein levels ([Figure 2](#F0002){ref-type="fig"}), which indicated that the aggregation properties of the protein produced by the transgenes were similar.

The levels of cell death induced by the four different *Aβ42* transgenes {#S003-S2002}
------------------------------------------------------------------------

Next, we examined the cell death induced by the transgenes in developing eyes, which have been used frequently to measure cell death (Lee et al. [@CIT0031]). Ectopic *Aβ42* expression resulted in severely reduced and rough eyes in the *UAS-Aβ42^2X^* lines when reared at both 25°C and 29°C ([Figure 3](#F0003){ref-type="fig"}(a)--(d)). However, the eye phenotype of flies expressing the *UAS-Aβ42^BL33770^* transgene depended on the rearing temperature. The reduced and rough eye phenotype appeared only at 29°C, while the rough eye phenotype without size reduction appeared at 25°C ([Figure 3](#F0003){ref-type="fig"}(a)--(d)). The flies expressing *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^* showed very mild rough eye phenotype at 29°C ([Figure 3](#F0003){ref-type="fig"}(b)). The number of dead cells in the developing eyes was consistently the highest in *UAS-Aβ42^2X^*, followed by *UAS-Aβ42^BL33770^*, *UAS-Aβ42^11C39^*, and *UAS-Aβ42^H29.3^* ([Figure 3](#F0003){ref-type="fig"}(e) and 3(f)). Figure 3.The morphology and cell death of *Drosophila* eyes expressing four *Aβ42* transgenes. (a, b) Pictures showing the eyes of flies expressing different *Aβ42* transgenes at different temperatures. Magnification of the pictures, ×50. (c, d) Graphs showing the relative sizes of the eyes of each experimental group (Tukey--Kramer test, *n* ≥ 19, \*\*\**p* \< .001, NS, not significant). (e) Fluorescent microscopic images of AO-stained eye imaginal discs expressing human *Aβ42* using four different transgenic lines at 29°C. Magnification of the pictures, ×200. (f) A graph showing the relative number of AO-positive signals in the eye imaginal disc of each experimental group (Tukey--Kramer test, *n* ≥ 17, \*\*\**p* \< .001).

The levels of ROS in the flies expressing the four different *Aβ42* transgenes {#S003-S2003}
------------------------------------------------------------------------------

ROS generation is an important pathological characteristic of AD, and ROS is closely associated with neuronal cell death (Markesbery [@CIT0041]); therefore, we also measured the ROS levels using DHE staining in the eye imaginal discs expressing the *Aβ42* transgenes. A prominent amount of ROS was detected in the eye imaginal discs expressing *UAS-Aβ42^2X^* and *UAS-Aβ42^BL33770^*, while little was observed in the discs expressing *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^* ([Figure 4](#F0004){ref-type="fig"}). Figure 4.The ROS levels in the flies expressing four different *Aβ42* transgenes. (a) Fluorescent microscopic images of DHE-stained eye imaginal discs expressing human *Aβ42* using four different transgenic lines at 29°C. Magnification of the pictures, ×200. (b) A graph showing ROS levels, which were detected by DHE staining (Tukey--Kramer test, *n* ≥ 18, \*\**p* \< .01, \*\*\**p* \< .001; NS, not significant).

The phenotypes of the flies expressing the *Aβ42* transgenes in neurons {#S003-S2004}
-----------------------------------------------------------------------

We also examined the effects of transgene expression in neurons during development by calculating the survival rates, which were the ratio of emerged adults from eggs. Interestingly, the trend of decreased survival in each *Aβ42-*expressing line was different from the levels of *Aβ42* expression or the eye phenotype ([Figure 5](#F0005){ref-type="fig"}(a)). The survival rate of the *UAS-Aβ42^BL33770^* flies was the lowest, while the *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^* flies also showed significantly reduced survival ([Figure 5](#F0005){ref-type="fig"}(a)). Figure 5.Survival rates and climbing ability of neuronal *Aβ42*-expressing flies with four different *Aβ42* transgenes. (a) A graph showing the survival rates of *Drosophila* expressing human *Aβ42* in their brains using four different transgenic lines at 25°C (Tukey--Kramer test, *n* ≥ 180, \*\*\**p* \< .001). (b) A graph showing the climbing ability of *Aβ42*-expressing flies at 25°C (Tukey--Kramer test, *n* ≥ 80, \**p* \< .05, \*\*\**p* \< .001).

To compare the effects of *Aβ42* expression on adult neurological function, the locomotor activities of the flies expressing the transgenes were measured. Surprisingly, the trend in the locomotor dysfunction levels in the *UAS-Aβ42^2X^* and *UAS-Aβ42^BL33770^* lines was quite different from that of their survival rates ([Figure 5](#F0005){ref-type="fig"}(b)). Although the survival rate of *UAS-Aβ42^BL33770^* flies was extremely low (12%), upon emerging, they only showed a moderate locomotor defect ([Figure 5](#F0005){ref-type="fig"}(b)), which suggested that the surviving flies may be relatively healthy.

Discussion {#S004}
==========

In this study, we compared the expression levels of *Aβ42* and the phenotypes of flies expressing four frequently used *UAS-Aβ42* transgenes. The relative expression levels of *Aβ42* in the transgenic lines are similar in both the developing eyes and brain. Both the Aβ42 proteins and its aggregation levels were consistently the highest in the developing eyes and brain of *UAS-Aβ42^2X^* line, followed by *UAS-Aβ42^BL33770^*, *UAS-Aβ42^11C39^*, and *UAS-Aβ42^H29.3^*. However, the effects of *Aβ42* expression on the phenotypes in these lines were different in these tissues. The eyes of flies expressing *UAS-Aβ42^2X^* or *UAS-Aβ42^BL33770^* showed severe defects, while *UAS-Aβ42^11C39^* or *UAS-Aβ42^H29.3^* flies had very mild rough eye phenotypes, which correlated with Aβ42 protein levels. In contrast, the severity of neuronal phenotypes in each transgenic line did not correlate with Aβ42 protein levels. When the transgenes were expressed pan-neuronally using the *elav-GAL4* driver, the survival rate was reduced significantly in both *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^*, unlike their eye phenotypes. This discrepancy in the effects of Aβ42 in the different tissues might be caused by the difference in susceptibility between neurons and non-neuronal cells. In support of this notion, a previous study showed that Aβ oligomer administration induced cell death in primary cultures of rat cortical neurons, but not in astrocytes (Ebenezer et al. [@CIT0012]). The hypersensitivity of neuronal cells to Aβ oligomers might reflect the high level of Aβ oligomer receptors, such as the receptor for advanced glycation end products (Du Yan et al. [@CIT0011]) and prions (Laurén et al. [@CIT0028]), or erroneous cell cycle activation by the Aβ protein in neurons (Caricasole et al. [@CIT0006]). Although the detailed mechanism is not clear, our data suggest that the Aβ hypersensitivity of neuronal cells is conserved in *Drosophila*.

We also found that the survival rate of the flies expressing *UAS-Aβ42^BL33770^* in neurons was the lowest, while *Aβ42* expression levels of these flies are much lower than that of flies expressing *UAS-Aβ42^2X^* transgene. This result suggests that the neurotoxicity of Aβ42 is not simply determined by Aβ42 levels. This phenomenon is also well known in human brain. That is, the degree of cognitive impairment in AD patients does not correlate well with the brain Aβ deposits number (Hardy & Selkoe [@CIT0017]). However, the soluble Aβ concentrations were inversely correlated with synapse loss in AD patients and distinguished AD patients from high pathology control patients (Lue et al. [@CIT0039]), which suggests that soluble Aβ42 oligomers, but not insoluble Aβ42 deposits, are responsible for AD pathology such as synapse loss. Therefore, the unexpected highly decreased survival rate of *Aβ42^BL33770^*-expressing flies would be the result from the high level of soluble Aβ42 oligomer generation in this line.

The difference between the constructs of the transgenes in different *UAS-Aβ42* lines might also be associated with their phenotypic variation. The different secretory abilities of the Aβ42 peptide expressed from each transgenic line might explain the unexpected strong reduction of survival during the development of flies expressing *UAS-Aβ42^11C39^* or *UAS-Aβ42^H29.3^* in neurons. As these lines contain a mammalian signal peptide, Aβ42 proteins might be secreted less efficiently in these lines compared to *UAS-Aβ42^2X^* and *UAS-Aβ42^BL33770^* lines, which contain a *Drosophila* signal peptide. In that case, flies with *UAS-Aβ42^11C39^* and *UAS-Aβ42^H29.3^* might secrete little Aβ42 out of the cells, resulting in intracellular Aβ42 accumulation that would damage mitochondria. In contrast, the *UAS-Aβ42^2X^* and *UAS-Aβ42^BL33770^* lines secreted most of the Aβ42 proteins outside the cells, while relatively little accumulates in the cytoplasm. Further studies on the Aβ42 secretion for each transgenic line are needed to reveal the detailed mechanism of Aβ42 cytotoxicity.

In addition, the effect of different genetic backgrounds should be considered. Although we used the same *GAL4* lines to express the four different *Aβ42* transgenes ectopically, the transgenic lines have different genetic backgrounds, which could affect the phenotypes produced by the transgenes. Therefore, to exclude this possibility completely, further studies should be conducted with the new transgenes with clear genetic backgrounds, which can be achieved by backcrossing to the same control line, such as *w^1118^*.

In conclusion, our data demonstrate that different *Drosophila* AD models show different phenotypic severity in different tissues, and suggest that different *Aβ42* transgenes might have different modes of cytotoxicity. Therefore, AD models should be designed for the specific aims of each study.
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